Stock comparison
Camurus AB (publ)
CAMX.ST$36.93BHealthcare Market cap, Sector
Illumina
ILMN$29.13BHealthcare Market cap, Sector
Overall winner
Camurus AB (publ)
CAMX.ST 70 ILMN
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
CAMX.ST7wins
0winsILMN
78B
D53
91A
D58
94A
D50
65C
D56
63C
D54
77B
D56
77B
D51
Side-by-side metrics
| Metric | CAMX.ST | ILMN |
|---|---|---|
| Market cap | Winner: $36.93B | $29.13B |
| P/E (TTM) | 42.6x | 25.6x Winner |
| EV/EBIT | 29.5x | 26.6x Winner |
| ROIC (TTM) | Winner: 17.17% | 13.79% |
| Gross margin | Winner: 93.11% | 67.66% |
| Net margin | Winner: 32.47% | 19.43% |
| Revenue CAGR 5y | Winner: 33.3% | -1.06% |
| EPS CAGR 5y | Winner: 132.79% | 1.91% |
| Debt / Equity | Winner: 0.0x | 0.9x |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
CAMX.ST leads on
- Revenue CAGR 5y33.3%vs -1.06%+103%
- EPS CAGR 5y132.79%vs 1.91%+99%
- Debt / Equity0.0xvs 0.9x+97%
- Net margin32.47%vs 19.43%+40%
ILMN leads on
- P/E (TTM)25.6xvs 42.6x+40%
- EV/EBIT26.6xvs 29.5x+10%
More like CAMX.ST
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.